Seven TVU backpacks enable seamless broadcast production and YouTube streaming for Inter Highschool Basketball Tournament in Osaka.
CUPERTINO, Calif., June 18, 2025 /PRNewswire/ -- OPTAGE Inc. (eo Hikari TV) successfully utilized seven TVU units, comprising TVU One and TVU PRS One backpacks, to deliver comprehensive coverage of the Inter-High School Basketball Tournament held on June 1st, 7th, and 8th, 2025. The deployment enabled simultaneous television broadcast recording and live YouTube streaming throughout the Inter Highschool Tournament.
The media production team implemented an efficient workflow addressing basketball broadcasting's unique challenges. Given the sport's fast-paced nature and critical requirement for real-time communication, all camera switching operations were performed directly at the venue to ensure immediate responsiveness to game action.
"Basketball is a fast-paced sport that requires zero-latency intercom communication, so camera switching was done on-site," explained Mr. Yamaguchi from the Media Production Team. "The switched output video, along with camera sources such as scoreboards and overhead shots, was transmitted in parallel to the station using TVU One and TVU PRS One backpacks. Final video mixing and commercial insertion were handled in the studio sub-control room at the station before transmission and recording."
The production workflow maximized TVU backpacks' parallel transmission capabilities, sending multiple video feeds simultaneously to the broadcast station's studio sub-control room. This approach allowed sophisticated post-production work including final video mixing and commercial insertion while maintaining the live broadcast schedule.
The TVU implementation delivered significant operational benefits that streamlined the entire production process. The advanced transmission systems achieved stable video transmission without requiring fiber optic installation at the venue, eliminating costly and time-consuming infrastructure work. The systems enabled parallel transmission of footage from cameras positioned in challenging remote locations, such as above the stands, significantly reducing on-site setup burden and cable management complexity.
Most importantly, there was virtually no delay difference between all seven TVU backpacks, dramatically reducing time needed for technical adjustments and synchronization. This consistency allowed the production team to focus on content creation rather than technical troubleshooting.
This successful deployment demonstrates how advanced transmission technology enhances sports broadcasting efficiency while maintaining broadcast-quality standards for both traditional television audiences and modern digital streaming platforms. The project establishes a compelling foundation for future sports broadcasting initiatives that demand flexibility, reliability, and professional-grade results across diverse venue configurations.
Photo - https://mma.prnasia.com/media2/2712636/Osaka.jpg?p=medium600
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
No More Cables or Delays: TVU Technology Streams Basketball Tournament Live
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
